Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 9 (4) , 238-244
Abstract
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic SocietyKeywords
This publication has 23 references indexed in Scilit:
- Cancer cachexia: understanding the molecular basisNature Reviews Cancer, 2014
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- EUS-guided celiac plexus interventions in pancreatic cancer pain: An update and controversies for the endosonographerEndoscopic Ultrasound, 2014
- Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhemTrends in Endocrinology & Metabolism, 2013
- A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two?Gastrointestinal Endoscopy, 2011
- Randomized, Double-Blind, Controlled Trial of Early Endoscopic Ultrasound–Guided Celiac Plexus Neurolysis to Prevent Pain Progression in Patients With Newly Diagnosed, Painful, Inoperable Pancreatic CancerJournal of Clinical Oncology, 2011
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine careApplied Physiology, Nutrition, and Metabolism, 2008
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- Endosonography-guided celiac plexus neurolysisGastrointestinal Endoscopy, 1996
- Clinical applications of visual analogue scales: a critical reviewPsychological Medicine, 1988